PharmaEssentia Corp.(TW:6446)
NT$1,335.00+55.00 (+4.30%)
TW:6446
PharmaEssentia Corp. financials statements
NT$1,335.00
At close:+55.00 (+4.30%)
PharmaEssentia Corp. (6446) Ratios
PharmaEssentia Corp. Ratios
TW:6446's free cash flow for Q2 2026 was NT$2.01B. For the 2026 fiscal year, TW:6446's free cash flow was decreased by NT$-385.09M and operating cash flow was NT$2.39B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.20 | 9.94 | 10.64 | 5.24 | 3.49 |
| Quick Ratio | 5.93 | 9.44 | 9.96 | 4.81 | 2.88 |
| Cash Ratio | 4.85 | 8.23 | 9.14 | 4.04 | 2.45 |
| Solvency Ratio | 1.00 | 0.93 | -0.11 | -0.36 | -1.33 |
| Operating Cash Flow Ratio | 1.13 | 1.00 | -0.33 | -0.59 | -1.74 |
| Short-Term Operating Cash Flow Coverage | 880.11 | 213.36 | -21.14 | -1.50 | -76.64 |
| Net Current Asset Value | NT$ 23.61B | NT$ 21.82B | NT$ 19.57B | NT$ 10.18B | NT$ 2.98B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.03 | 0.04 | 0.10 | 0.09 |
| Debt-to-Equity Ratio | 0.03 | 0.04 | 0.05 | 0.13 | 0.13 |
| Debt-to-Capital Ratio | 0.03 | 0.03 | 0.05 | 0.11 | 0.11 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
| Financial Leverage Ratio | 1.17 | 1.13 | 1.14 | 1.26 | 1.46 |
| Debt Service Coverage Ratio | 173.44 | 98.32 | -3.85 | -1.10 | -61.14 |
| Interest Coverage Ratio | 193.04 | 78.23 | -40.98 | -109.47 | -283.09 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Interest Debt Per Share | 2.38 | 2.73 | 3.49 | 5.04 | 1.89 |
| Net Debt to EBITDA | -4.04 | -5.93 | 27.50 | 5.47 | 1.13 |
| Profitability Margins | |||||
| Gross Profit Margin | 87.47% | 87.91% | 88.04% | 71.82% | 42.29% |
| EBIT Margin | 32.03% | 30.99% | -18.42% | -63.27% | -426.66% |
| EBITDA Margin | 34.58% | 34.77% | -13.15% | -55.36% | -392.07% |
| Operating Profit Margin | 31.52% | 17.83% | -37.48% | -70.37% | -429.91% |
| Pretax Profit Margin | 31.87% | 30.76% | -19.33% | -63.91% | -428.17% |
| Net Profit Margin | 32.27% | 30.46% | -12.22% | -47.70% | -428.17% |
| Continuous Operations Profit Margin | 32.27% | 30.46% | -12.22% | -47.70% | -428.17% |
| Net Income Per EBT | 101.25% | 99.03% | 63.21% | 74.64% | 100.00% |
| EBT Per EBIT | 101.11% | 172.50% | 51.58% | 90.81% | 99.60% |
| Return on Assets (ROA) | 13.49% | 9.55% | -2.29% | -8.97% | -45.35% |
| Return on Equity (ROE) | 15.78% | 10.80% | -2.60% | -11.32% | -66.13% |
| Return on Capital Employed (ROCE) | 15.06% | 6.09% | -7.62% | -15.87% | -58.97% |
| Return on Invested Capital (ROIC) | 14.96% | 5.99% | -4.77% | -10.92% | -57.64% |
| Return on Tangible Assets | 13.57% | 9.63% | -2.31% | -9.11% | -47.23% |
| Earnings Yield | 3.22% | 1.64% | -0.61% | -1.13% | -4.15% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.36 | 3.62 | 3.45 | 3.44 | 1.33 |
| Payables Turnover | 12.50 | 9.31 | 4.74 | 3.52 | 2.15 |
| Inventory Turnover | 1.51 | 0.92 | 0.42 | 0.74 | 0.44 |
| Fixed Asset Turnover | 2.96 | 2.73 | 1.87 | 2.83 | 0.86 |
| Asset Turnover | 0.42 | 0.31 | 0.19 | 0.19 | 0.11 |
| Working Capital Turnover Ratio | 0.66 | 0.45 | 0.32 | 0.40 | 0.20 |
| Cash Conversion Cycle | 321.21 | 457.58 | 900.74 | 497.55 | 934.02 |
| Days of Sales Outstanding | 108.54 | 100.96 | 105.77 | 106.11 | 274.00 |
| Days of Inventory Outstanding | 241.88 | 395.82 | 872.02 | 495.20 | 829.87 |
| Days of Payables Outstanding | 29.20 | 39.20 | 77.04 | 103.76 | 169.85 |
| Operating Cycle | 350.41 | 496.78 | 977.79 | 601.31 | 1103.88 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 14.29 | 7.05 | -1.97 | -4.78 | -8.53 |
| Free Cash Flow Per Share | 9.12 | 4.55 | -5.69 | -5.79 | -8.87 |
| Dividend Paid and CapEx Coverage Ratio | 2.32 | 2.82 | -0.53 | -4.69 | -25.16 |
| Capital Expenditure Coverage Ratio | 2.76 | 2.82 | -0.53 | -4.69 | -25.16 |
| Operating Cash Flow Coverage Ratio | 6.17 | 2.64 | -0.59 | -0.96 | -4.59 |
| Operating Cash Flow to Sales Ratio | 0.34 | 0.26 | -0.14 | -0.52 | -3.75 |
| Free Cash Flow Yield | 2.15% | 0.91% | -2.00% | -1.50% | -3.77% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 31.06 | 61.84 | -163.14 | -88.79 | -24.14 |
| Price-to-Sales (P/S) Ratio | 10.02 | 18.53 | 19.89 | 42.38 | 103.30 |
| Price-to-Book (P/B) Ratio | 4.90 | 6.57 | 4.24 | 10.06 | 15.95 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 46.46 | 109.79 | -49.94 | -66.88 | -26.49 |
| Price-to-Operating Cash Flow Ratio | 29.66 | 70.84 | -143.91 | -81.12 | -27.54 |
| Price-to-Earnings Growth (PEG) Ratio | 0.45 | -0.11 | 2.71 | 1.61 | -0.67 |
| Enterprise Value Multiple | 24.94 | 47.37 | -123.71 | -71.08 | -25.21 |
| Enterprise Value | 134.86B | 160.34B | 83.07B | 113.40B | 64.90B |
| EV to EBITDA | 24.94 | 47.37 | -123.71 | -71.08 | -25.21 |
| EV to Sales | 8.63 | 16.47 | 16.27 | 39.35 | 98.85 |
| EV to Free Cash Flow | 39.98 | 97.57 | -40.86 | -62.09 | -25.35 |
| EV to Operating Cash Flow | 25.52 | 62.95 | -117.74 | -75.32 | -26.36 |
| Tangible Book Value Per Share | 85.81 | 75.30 | 66.21 | 37.77 | 13.88 |
| Shareholders’ Equity Per Share | 86.45 | 76.06 | 66.96 | 38.52 | 14.73 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.01 | 0.37 | 0.25 | 0.00 |
| Revenue Per Share | 42.27 | 26.96 | 14.28 | 9.14 | 2.28 |
| Net Income Per Share | 13.64 | 8.21 | -1.74 | -4.36 | -9.74 |
| Tax Burden | 1.01 | 0.99 | 0.63 | 0.75 | 1.00 |
| Interest Burden | 0.99 | 0.99 | 1.05 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.22 | 0.27 | 0.44 | 0.49 | 1.94 |
| SG&A to Revenue | 0.34 | 0.43 | 0.82 | 0.93 | 2.78 |
| Stock-Based Compensation to Revenue | 0.00 | 0.02 | 0.14 | 0.08 | 0.76 |
| Income Quality | 1.05 | 0.85 | 1.13 | 0.82 | 0.88 |
Currency in TWD
